Exchange Traded Concepts, LLC Blueprint Medicines Corp Transaction History
Exchange Traded Concepts, LLC
- $5.43 Billion
- Q1 2025
A detailed history of Exchange Traded Concepts, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 1,383 shares of BPMC stock, worth $140,844. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,383
Previous 2,009
31.16%
Holding current value
$140,844
Previous $175,000
30.29%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding BPMC
# of Institutions
394Shares Held
61.2MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$690 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$677 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$578 Million0.06% of portfolio
-
State Street Corp Boston, MA2.5MShares$255 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL1.94MShares$198 Million0.44% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.08B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...